These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 9252167

  • 1. Ribavirin and interferon for recurrent posttransplantation HCV infection: to treat or not to treat?
    McHutchison JG.
    Hepatology; 1997 Aug; 26(2):505-6. PubMed ID: 9252167
    [No Abstract] [Full Text] [Related]

  • 2. Ribavirin/interferon-alpha sequential treatment of recurrent hepatitis C after liver transplantation.
    Giostra E, Kullak-Ublick GA, Keller W, Fried R, Vanlemmens C, Kraehenbuhl S, Locher S, Egger HP, Clavien PA, Hadengue A, Mentha G, Morel P, Negro F.
    Transpl Int; 2004 May; 17(4):169-76. PubMed ID: 15060764
    [Abstract] [Full Text] [Related]

  • 3. A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C.
    Shakil AO, McGuire B, Crippin J, Teperman L, Demetris AJ, Conjeevaram H, Gish R, Kwo P, Balan V, Wright TL, Brass C, Rakela J.
    Hepatology; 2002 Nov; 36(5):1253-8. PubMed ID: 12395337
    [Abstract] [Full Text] [Related]

  • 4. Recurrent hepatitis C after liver transplantation: a nonrandomized trial of interferon alfa alone versus interferon alfa and ribavirin.
    Ahmad J, Dodson SF, Demetris AJ, Fung JJ, Shakil AO.
    Liver Transpl; 2001 Oct; 7(10):863-9. PubMed ID: 11679984
    [Abstract] [Full Text] [Related]

  • 5. Combined therapy with interferon and low-dose ribavirin in posttransplantation recurrent hepatitis C: a pragmatic study.
    Alberti AB, Belli LS, Airoldi A, de Carlis L, Rondinara G, Minola E, Vangeli M, Cernuschi A, D'Amico M, Forti D, Pinzello G.
    Liver Transpl; 2001 Oct; 7(10):870-6. PubMed ID: 11679985
    [Abstract] [Full Text] [Related]

  • 6. Dual hepatitis B virus and hepatitis C virus infection: To treat or not to treat, and how?
    Husa P.
    J Gastroenterol Hepatol; 2005 May; 20(5):669-70. PubMed ID: 15853976
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
    Abdelmalek MF, Firpi RJ, Soldevila-Pico C, Reed AI, Hemming AW, Liu C, Crawford JM, Davis GL, Nelson DR.
    Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis C: new treatment overview.
    Stoia J.
    AIDS Treat News; 1998 Sep 04; (302):5-6. PubMed ID: 11365763
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Retreatment of hepatitis C patients who do not respond to interferon: the search continues.
    Pianko S, McHutchison J.
    Am J Gastroenterol; 2000 May 04; 95(5):1122-4. PubMed ID: 10811315
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of recurrent hepatitis C post-liver transplantation.
    Marroni CA.
    Ann Hepatol; 2010 May 04; 9 Suppl():84-91. PubMed ID: 20714002
    [Abstract] [Full Text] [Related]

  • 14. Successful treatment of fibrosing cholestatic hepatitis with pegylated interferon, ribavirin and sofosbuvir after a combined kidney-liver transplantation.
    Delabaudière C, Lavayssière L, Dörr G, Muscari F, Danjoux M, Sallusto F, Peron JM, Bureau C, Rostaing L, Izopet J, Kamar N.
    Transpl Int; 2015 Feb 04; 28(2):255-8. PubMed ID: 25159822
    [Abstract] [Full Text] [Related]

  • 15. [Therapy with interferon plus ribavirin in hemodialysis patient with PCR-positive viral hepatitis C].
    Arambarri M, Fernández Lucas M, Echarri R, Teruel JL, Alarcón C, Merino JL, Ortuño J.
    Nefrologia; 2004 Feb 04; 24 Suppl 3():39-42. PubMed ID: 15219067
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Interferon-alpha and ribavirin combination therapy for co-infection of hepatitis C virus and human immunodeficiency virus].
    Zheng YH, He Y, Yang X, Gong GZ, Zhou HY, Zhang CY, Zhou W, Huang L, Ding PP, Li H.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct 04; 13(10):741-4. PubMed ID: 16248945
    [Abstract] [Full Text] [Related]

  • 18. Editorial comment: erythropoietin for treatment-related anemia in persons with hepatitis C--questions remain.
    Yachimski P, Chung RT.
    AIDS Read; 2004 Oct 04; 14(10):568-9. PubMed ID: 15510393
    [No Abstract] [Full Text] [Related]

  • 19. Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.
    Raziorrouh B, Jung MC, Schirren CA, Loehe F, Thiel M, Nitschko H, Diepolder H, Ulsenheimer A, Heeg M, Zachoval R, Gruener NH.
    Eur J Gastroenterol Hepatol; 2008 Aug 04; 20(8):778-83. PubMed ID: 18617783
    [Abstract] [Full Text] [Related]

  • 20. Polymorphisms in the interferon-gamma gene at position +874 in patients with chronic hepatitis C treated with high-dose interferon-alpha and ribavirin.
    Dai CY, Chuang WL, Chang WY, Chen SC, Lee LP, Hsieh MY, Hou NJ, Lin ZY, Hsieh MY, Wang LY, Yu ML.
    Antiviral Res; 2005 Aug 04; 67(2):93-7. PubMed ID: 16051377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.